APA

Schäfer R., Kehlbach R., Müller M., Bantleon R., Kluba T., Ayturan M., Siegel G., Wolburg H., Northoff H., Dietz K., Claussen C. D. & Wiskirchen J. (20090429). Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability. : Cytotherapy.

Chicago

Schäfer Richard, Kehlbach Rainer, Müller Michaela, Bantleon Rüdiger, Kluba Torsten, Ayturan Miriam, Siegel Georg, Wolburg Hartwig, Northoff Hinnak, Dietz Klaus, Claussen Claus D and Wiskirchen Jakub. 20090429. Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability. : Cytotherapy.

Harvard

Schäfer R., Kehlbach R., Müller M., Bantleon R., Kluba T., Ayturan M., Siegel G., Wolburg H., Northoff H., Dietz K., Claussen C. D. and Wiskirchen J. (20090429). Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability. : Cytotherapy.

MLA

Schäfer Richard, Kehlbach Rainer, Müller Michaela, Bantleon Rüdiger, Kluba Torsten, Ayturan Miriam, Siegel Georg, Wolburg Hartwig, Northoff Hinnak, Dietz Klaus, Claussen Claus D and Wiskirchen Jakub. Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability. : Cytotherapy. 20090429.